Australia

Showing: 1 - 2 of 2 Articles

A group of pediatric patients undergoing treatment, symbolizing Fennec Pharmaceuticals and Norgine's partnership to bring PEDMARQSI® to pediatric cancer patients.

Pharmaceuticals News

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, and Norgine, a …

vinay March 18, 2024March 18, 2024

Pharmaceuticals News

PharmaTher’s Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, …

vinay February 21, 2024February 21, 2024